These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17805516)

  • 1. Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats.
    Kelsey JE; Calabro S
    Psychopharmacology (Berl); 2008 Jul; 198(4):461-6. PubMed ID: 17805516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol.
    Biała G; Budzyńska B
    Pharmacol Rep; 2010; 62(5):797-807. PubMed ID: 21098863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
    Fang Q; Li FQ; Li YQ; Xue YX; He YY; Liu JF; Lu L; Wang JS
    Pharmacol Biochem Behav; 2011 Oct; 99(4):738-42. PubMed ID: 21722663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats.
    Forget B; Barthélémy S; Saurini F; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2006 Nov; 189(1):59-69. PubMed ID: 16969683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.
    Le Foll B; Goldberg SR
    Neuroreport; 2004 Sep; 15(13):2139-43. PubMed ID: 15486497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
    Forget B; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2005 Oct; 181(4):722-34. PubMed ID: 15986197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT.
    Bhatti AS; Aydin C; Oztan O; Ma Z; Hall P; Tao R; Isgor C
    Psychopharmacology (Berl); 2009 Mar; 203(1):23-32. PubMed ID: 18936914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors.
    Ramiro-Fuentes S; Fernandez-Espejo E
    Psychopharmacology (Berl); 2011 Apr; 214(4):949-59. PubMed ID: 21128069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
    Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
    Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
    Gerdeman GL; Schechter JB; French ED
    Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.
    Werling LL; Reed SC; Wade D; Izenwasser S
    Int J Dev Neurosci; 2009 May; 27(3):263-9. PubMed ID: 19167478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
    López-Moreno JA; González-Cuevas G; Navarro M
    Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
    Celik E; Uzbay IT; Karakas S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats.
    Kelsey JE; Beer T; Lee E; Wagner A
    Psychopharmacology (Berl); 2002 Jun; 161(4):370-8. PubMed ID: 12073164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice.
    Marinho EA; Oliveira-Lima AJ; Santos R; Hollais AW; Baldaia MA; Wuo-Silva R; Yokoyama TS; Takatsu-Coleman AL; Patti CL; Longo BM; Berro LF; Frussa-Filho R
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():22-31. PubMed ID: 25496830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of risperidone on development and expression of nicotine-induced locomotor sensitization in rats.
    Akdag E; Kayir H; Uzbay TI
    Synapse; 2011 Aug; 65(8):708-14. PubMed ID: 21108239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'.
    Gardner A; Mallet PE
    Eur J Pharmacol; 2006 Jan; 530(1-2):103-6. PubMed ID: 16380113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251.
    Aydin C; Oztan O; Isgor C
    Neuropharmacology; 2012 Dec; 63(8):1335-45. PubMed ID: 22959963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.